Physician profile
Doantrang T Du
NPI 1699782474
$1,252.79
in general payments reported to CMS, 2019-2025
17 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.57 · 2020: $87.03 · 2021: $163 · 2022: $230 · 2023: $197 · 2024: $270 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $305.02 | 2024-2025 | Zenpep |
| Abbvie INC. | $273.26 | 2020-2025 | Dalvance, Creon, Teflaro |
| Philips North America LLC | $187.85 | 2020-2025 | Vest Therapy Und |
| Vertex Pharmaceuticals Incorporated | $141.22 | 2020-2025 | |
| Electromed, INC. | $61.24 | 2021-2023 | Smartvest |
| Allergan, INC. | $42.34 | 2019 | |
| Pfizer INC. | $33.23 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $32.91 | 2021 | |
| Janssen Biotech, INC. | $29.49 | 2019-2024 | Talvey, Tecvayli |
| Gilead Sciences, INC. | $26.69 | 2021-2022 | |
| Baxter Healthcare | $20.80 | 2025 | |
| Mylan Specialty L.P. | $20.15 | 2024 | Tobi Podhaler |
| Novo Nordisk INC | $18.57 | 2025 | Ozempic, Rybelsus |
| Chiesi USA, INC. | $18.13 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.41 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.16 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doantrang Du listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.